Skip to main content
. 2022 Mar 9;14:1087–1098. doi: 10.2147/CMAR.S352308

Figure 2.

Figure 2

Diagnostic and prognostic roles of SLC9A3-AS1 in NSCLC. (A) ROC curve for serum SLC9A3-AS1 to distinguish NSCLC from LBL. (B) ROC curve for serum SLC9A3-AS1 to distinguish NSCLC from HC. (C and D) Kaplan-Meier curves for overall survival (C) and recurrence-free survival (D) in NSCLC patients stratified by SLC9A3-AS1 expression.

Abbreviations: NSCLC, non-small cell lung cancer; LBL, lung benign lesion; HC, healthy control; ROC, receiver operating characteristic curve.